Abstract:Many chronic inflammatory diseases, such as autoimmune inflammation, are associated with M1 macrophages, and the key to their treatment is blocking inflammation. Oxymatrine (OMT), a traditional Chinese medicine, has a marked anti-inflammatory effect. However, its anti-inflammatory target and mechanism in M1 cells remain unclear, which limits its clinical application. In this study, we investigated the anti-inflammatory effects of oxymatrine (OMT) on the M1 inflammatory response. We also determined the relationship between OMT treatment and the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) pathway with OMT treatment. To this end, we induced the differentiation of human peripheral blood monocytes (THP-1) into M1 cells. THP-1 cells were induced with a phorbol ester (phorbol-12-myristate-13-acetate (PMA)) and differentiated into naïve M0 macrophages. M0 cells were induced into M1 cells using lipopolysaccharide (LPS). The experimental groups were divided into the M0 macrophage group (NC), M1 inflammatory response group (LPS group), and M1 group treated with different concentrations of OMT (LPS + OMT-L, LPS + OMT-M, LPS + OMT-H). The cells in the OMT-treated groups were treated with OMT for 6 h, followed by LPS for 24 h, and the LPS group was treated with LPS only. The resulting supernatants and cells were collected. The secretion levels of NO were detected by the Griess method and the secretion levels of TNF-α and IL-1β in the supernatants were detected by the ELISA method. The secretion levels of these inflammatory factors were reduced in every OMT-treated group compared to the LPS group (P < 0.01), and the most significant reductions were found in the OMT-H group (P < 0.0001). By western blotting, the protein expression levels of TLR4, NF-κB, NLRP3, and Caspase-1 were all found to be downregulated in the cells of OMT-treated groups compared to the LPS group (P < 0.0001). In situ changes in NLRP3 expression were observed using immunofluorescence. The fluorescence intensity of NLRP3 in M1 cells was weaker in all OMT intervention groups than in the LPS group (P < 0.001). In conclusion, OMT has significant anti-inflammatory effects on the M1 inflammatory responses, and the TLR4/NF-κB/NLRP3 pathway was blocked proportional to the concentration of OMT.

Oxymatrine Induces Liver Injury Through JNK Signalling Pathway Mediated by TNF‐α in Vivo

Oxymatrine Causes Hepatotoxicity by Promoting the Phosphorylation of JNK and Induction of Endoplasmic Reticulum Stress Mediated by ROS in LO2 Cells

Oxymatrine Reduces Neuronal Cell Apoptosis by Inhibiting Toll-like Receptor 4/nuclear Factor Kappa-B-dependent Inflammatory Responses in Traumatic Rat Brain Injury

Neuroprotective Effects of Oxymatrine Against Excitotoxicity Partially Through Down-Regulation of NR2B-containing NMDA Receptors.

A proteomics-based study of the mechanism of oxymatrine to ameliorate hepatic fibrosis in mice

Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis

Effect of oxymatrine HSPC liposomes on improving bioavailability, liver target distribution and hepatoprotective activity of oxymatrine.

Oxymatrine attenuates sepsis‐induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF‐κB signaling pathway

Oxymatrine Inhibits Microglia Activation Via HSP60-TLR4 Signaling.

The Role of Oxymatrine in Regulating TGF-β1 in Rats with Hepatic Fibrosis

Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase

Oxymatrine protects against myocardial injury via inhibition of JAK2/STAT3 signaling in rat septic shock.

Effect of Oxymatrine on NF-κB/TNF-a Signaling in Rat Renal Tissue with Sepsis

Oxymatrine protects articular chondrocytes from IL-1β-induced damage through autophagy activation via AKT/mTOR signaling pathway inhibition

Toxic Markers Of Matrine Determined Using H-1-Nmr-Based Metabolomics In Cultured Cells In Vitro And Rats In Vivo

Oxymatrine Protects Against Sepsis-Induced Myocardial Injury Via Inhibition of the TNF-α/p38-MAPK/caspase-3 Signaling Pathway

[Prophylactic and Therapeutic Effect of Oxymatrine on D-galactosamine-induced Rat Liver Fibrosis].

Oxymatrine (OMT) Inhibits Lung Cancer Growth through Mitogen Activated Protein Kinase JNK/ERK/p38MAPKs Activation

Protective Effect of Oxymatrine Against Cardiac Myocytes Injury Induced by Aldosterone via MAPK Signaling Pathway

Prevention of Oleic Acid-Induced Acute Lung Injury of Rats with Oxymatrine

Oxymatrine blocks the NLRP3 inflammasome pathway, partly downregulating the inflammatory responses of M1 macrophages differentiated from THP-1 monocytes